Isatuximab induces antitumor activity in blastic plasmacytoid dendritic cell neoplasm through cellular cytotoxicity

Leukemia. 2026 Mar 31. doi: 10.1038/s41375-026-02947-w. Online ahead of print.

Nobuhiko Yamauchi¹, Yuko Mishima^{1

2}, Tomoko Takayama², Sayuri Minowa², Yuka Morita¹, Mamiko Momoki¹, Fuka Mima¹, Yukako Teramoto¹, Yusuke Koba¹, Yuko Shirouchi¹, Yuko Ishihara¹, Norihito Inoue^{3

4}, Misayo Miyake^{3

4}, Naoko Tsuyama^{3

4}, Kengo Takeuchi^{3

4

5}, Dai Maruyama^{6

7}

¹ Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
² Division of Clinical Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
³ Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
⁴ Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
⁵ Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
⁶ Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. dai.maruyama@jfcr.or.jp.
⁷ Division of Clinical Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan. dai.maruyama@jfcr.or.jp.

No abstract available

Publication types